SRAD jumped 16% on the week to $14.20 after reporting Q3 results on November 3, yet the post-earnings analyst reaction captured almost every shade of opinion simultaneously. The Street response was busy and split in direction. JP Morgan lowered its target to $12 from $13 while holding Neutral, putting the firm effectively below the current price. Truist, StoneX, and Needham each…
SRAD utilization hits 97.68%, near its 52-week high of 100%, as available shares to borrow tighten to just 16.4% of short interest.
Key data as of 10 Nov 2026
SRAD utilization hits 97.68%, near its 52-week high of 100%, as available shares to borrow tighten to just 16.4% of short interest.
6 Utilization updates in 30 days
Ten analyst firms slashed targets on SRAD in 48 hours. Options traders promptly ignored them. That split is the defining tension in Sportradar right now. The wall of target cuts tells one story. A put-call ratio at its…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SRAD — free to start on ORTEX.
Sign up for free →Open SRAD on ORTEX